New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
07:13 EDTDCTHDelcath Systems announces reimbursement for Chemostat in Chermany
Delcath Systems announced that the Institut für das Entgeltsystem im Krankenhaus, the German federal reimbursement agency, has established a reimbursement pathway for the treatment of patients with liver metastases with the Delcath Hepatic CHEMOSAT Delivery System for melphalan hydrochloride. The Value 4 status given to the CHEMOSAT procedure, while not mandating reimbursement, allows participating cancer centers to negotiate reimbursement coverage for the CHEMOSAT procedure with all insurers serving their region. Under the NUB scheme, reimbursement pathways will potentially be available for treatment with CHEMOSAT regardless of primary cancer origin.
News For DCTH From The Last 14 Days
Check below for free stories on DCTH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
13:05 EDTDCTHLinkedto says $3 per share bid for Delcath Systems dropped
Subscribe for More Information
September 15, 2014
10:33 EDTDCTHLinkedto says two public companies interested in Delcath Systems
Subscribe for More Information
07:06 EDTDCTHDelcath Systems appoints Dr. Jennifer Simpson as Interim-CEO
Delcath Systems announced the reorganization of the company's leadership as Dr. Jennifer Simpson has been appointed interim president and interim CEO. Dr. Simpson has served as interim co-president and interim Co-CEO of Delcath since September 2013. Dr. Graham Miao, who has served as interim co-president, interim Co-CEO and CFO will be leaving the company at the end of September to pursue other opportunities. Barbra Keck, currently vice president, Controller & Principal Accounting Officer will assume the responsibilities of Principal Financial Officer. In addition, Dr. Roger G. Stoll, who has been a member of the Delcath board since 2008, has been appointed to the newly created position of Executive Chairman. He succeeds Gabriel Leung, who is stepping down from his position as chairman. Leung will remain on the Board, but his schedule demands inhibited his ability to continue as chairman.
September 9, 2014
12:52 EDTDCTHLinkedto raises unsolicited bid for Delcath Systems to $3.00 per share
Subscribe for More Information
September 8, 2014
09:44 EDTDCTHLinkedto raises unsolicited bid for Delcath Systems to $2.90 per share
Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use